ATAI Life Sciences NV (FRA:9VC) Long-Term Debt : €18.32 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Long-Term Debt?

ATAI Life Sciences NV's Long-Term Debt for the quarter that ended in Sep. 2024 was €18.32 Mil.

ATAI Life Sciences NV's quarterly Long-Term Debt declined from Mar. 2024 (€18.08 Mil) to Jun. 2024 (€17.24 Mil) but then increased from Jun. 2024 (€17.24 Mil) to Sep. 2024 (€18.32 Mil).

ATAI Life Sciences NV's annual Long-Term Debt increased from Dec. 2021 (€0.66 Mil) to Dec. 2022 (€14.27 Mil) and increased from Dec. 2022 (€14.27 Mil) to Dec. 2023 (€16.39 Mil).

ATAI Life Sciences NV Long-Term Debt Historical Data

The historical data trend for ATAI Life Sciences NV's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Long-Term Debt Chart

ATAI Life Sciences NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

0.14

1.79

0.66

14.27

16.39

ATAI Life Sciences NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial															14.40	16.39	18.08	17.24	18.32

ATAI Life Sciences NV (FRA:9VC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

ATAI Life Sciences NV Long-Term Debt Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

ATAI:USA ATAI:Mexico

Address

Wallstrasse 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV Headlines

No Headlines